10-99877332-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015221.4(DNMBP):āc.4553A>Gā(p.Tyr1518Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000446 in 1,609,374 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.00040 ( 0 hom., cov: 32)
Exomes š: 0.00045 ( 8 hom. )
Consequence
DNMBP
NM_015221.4 missense
NM_015221.4 missense
Scores
6
7
6
Clinical Significance
Conservation
PhyloP100: 4.89
Genes affected
DNMBP (HGNC:30373): (dynamin binding protein) This gene encodes a protein belonging to the guanine nucleotide exchange factor family, and which regulates the configuration of cell junctions. It contains multiple binding sites for dynamin and thus links dynamin to actin regulatory proteins. Polymorphisms in this gene have been linked to Alzheimer's disease in some populations, though there are conflicting reports of such linkages in other populations. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.21488997).
BS2
High Homozygotes in GnomAdExome4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNMBP | NM_015221.4 | c.4553A>G | p.Tyr1518Cys | missense_variant | 17/17 | ENST00000324109.9 | NP_056036.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNMBP | ENST00000324109.9 | c.4553A>G | p.Tyr1518Cys | missense_variant | 17/17 | 1 | NM_015221.4 | ENSP00000315659.4 | ||
DNMBP | ENST00000543621.6 | c.2417A>G | p.Tyr806Cys | missense_variant | 14/14 | 1 | ENSP00000443657.2 | |||
DNMBP | ENST00000636706.1 | c.3449A>G | p.Tyr1150Cys | missense_variant | 14/14 | 2 | ENSP00000489875.1 |
Frequencies
GnomAD3 genomes AF: 0.000402 AC: 61AN: 151730Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
61
AN:
151730
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000669 AC: 165AN: 246774Hom.: 1 AF XY: 0.000742 AC XY: 99AN XY: 133468
GnomAD3 exomes
AF:
AC:
165
AN:
246774
Hom.:
AF XY:
AC XY:
99
AN XY:
133468
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000450 AC: 656AN: 1457524Hom.: 8 Cov.: 31 AF XY: 0.000497 AC XY: 360AN XY: 724952
GnomAD4 exome
AF:
AC:
656
AN:
1457524
Hom.:
Cov.:
31
AF XY:
AC XY:
360
AN XY:
724952
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000402 AC: 61AN: 151850Hom.: 0 Cov.: 32 AF XY: 0.000391 AC XY: 29AN XY: 74198
GnomAD4 genome
AF:
AC:
61
AN:
151850
Hom.:
Cov.:
32
AF XY:
AC XY:
29
AN XY:
74198
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
87
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2024 | The c.4553A>G (p.Y1518C) alteration is located in exon 17 (coding exon 16) of the DNMBP gene. This alteration results from a A to G substitution at nucleotide position 4553, causing the tyrosine (Y) at amino acid position 1518 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;N
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;.;D
REVEL
Pathogenic
Sift
Pathogenic
.;.;D
Sift4G
Pathogenic
.;.;D
Polyphen
1.0
.;.;D
Vest4
0.78
MVP
MPC
0.70
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at